Position in ABBV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$12,073,687
+$2,176,370 QoQ
Shares Held
47,980
+5.4% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#820
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2021CallValue
$10,787
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valeo Financial Advisors, LLC holds $209,939,553 across 14 Drug Manufacturers - General names. ABBV ranks #3 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
130,247 | $156,222,172 | |
| 2 | JNJ |
Johnson & Johnson
|
62,574 | $15,891,918 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
47,980 | $12,073,687 | |
| 4 | MRK |
Merck & Co., Inc.
|
54,116 | $6,953,906 | |
| 5 | AMGN |
Amgen Inc
|
17,375 | $6,291,835 | |
| 6 | PFE |
Pfizer Inc
|
169,378 | $4,078,622 | |
| 7 | AZN |
Astrazeneca PLC
|
9,817 | $1,861,499 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,784 | $1,716,154 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,073,687 | 47,980 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $9,897,317 | 45,507 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,163,436 | 53,234 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $12,153,303 | 52,489 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $9,890,761 | 53,285 | Shares | Sole | 2025-09-12 | |
| 2025-03-31 | $17,447,568 | 83,274 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $14,526,086 | 81,745 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $15,895,165 | 80,490 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $13,730,690 | 80,053 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $14,701,297 | 80,732 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $12,199,083 | 78,719 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $11,840,133 | 79,432 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $10,326,111 | 76,643 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $11,896,492 | 74,647 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $11,646,909 | 72,068 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $9,789,948 | 72,945 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $10,644,926 | 69,502 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $13,175,490 | 81,275 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $11,024,809 | 81,424 | Shares | Sole | 2022-01-07 | |
| 2021-09-30 | $8,781,480 | 81,408 | Shares | Sole | 2021-11-02 | |
| 2021-09-30 | $10,787 | 100 | Call | Sole | 2021-11-02 | |
| 2021-06-30 | $8,495,872 | 75,425 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $8,233,594 | 76,082 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $10,526,094 | 98,237 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $2,831,083 | 32,322 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $3,154,130 | 32,126 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $2,209,357 | 28,998 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||